Stocks
Denali Therapeutics (DNLI) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.43 | 123.1 | -16.1 | -6.71 | -10.9 | -5.12 | ||
| Changes by years, y/y, % | -79% | -2 015% | -113% | -58% | +63% | -19.0% | |||
Denali Therapeutics. EV/EBITDA
Denali Therapeutics. EV/EBITDA, changes, %
Denali Therapeutics (DNLI) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -10.9 | -10.3 | -10.8 | -6.31 | -8.37 | -5.12 | |
| Changes by years, y/y, % | +21% | +41% | +118% | -66% | -23% | |||
| Changes by quarters, q/q, % | -41% | -6% | +5% | -42% | +33% | |||
